Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ELDN
Stock Latest News
The Fly
Eledon Pharmaceuticals announces common stock, warrant offering, no amount given
10h ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals options imply 8.0% move in share price post-earnings
13h ago
ELDN
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
4d ago
HD
AMD
Premium
Ratings
Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
5d ago
ELDN
Premium
Market News
Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
5d ago
ELDN
Premium
Company Announcements
Eledon Pharmaceuticals Reports Promising Phase 2 Trial Results
5d ago
8K
ELDN
Premium
Company Announcements
Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart
16d ago
ELDN
Premium
Company Announcements
Eledon Pharmaceuticals’ AT 1501: A Promising Kidney Transplant Study Update
16d ago
ELDN
Premium
Ratings
Eledon Pharmaceuticals’ Tegoprubart: A Promising Buy Rating Amid Unmet Needs in Kidney Transplantation
2M ago
ELDN
Premium
Ratings
Eledon Pharmaceuticals: Promising Developments and Strong Financial Outlook Justify Buy Rating
2M ago
ELDN
Premium
Company Announcements
Eledon Pharmaceuticals Advances in Transplant Trials
3M ago
ELDN
Premium
Ratings
Buy Rating for Eledon Pharmaceuticals: Promising Kidney Transplant Treatment and Strong Financial Position
3M ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals reports Q2 EPS (13c), consensus (23c)
3M ago
ELDN
Premium
Ratings
Positive Outlook for Eledon Pharmaceuticals Driven by Promising Tegoprubart Phase 1b Study Results
3M ago
ELDN
Premium
Ratings
Promising Phase 1b Results of Tegoprubart Support Buy Rating for Eledon Pharmaceuticals
3M ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals announces updated data from tegoprubart trial
3M ago
ELDN
Premium
Company Announcements
Eledon Pharmaceuticals Reports Promising Phase 1b Trial Results
3M ago
8K
ELDN
Premium
The Fly
Craig-Hallum bullish on Eledon Pharmaceuticals, initiates with a Buy
4M ago
ELDN
Premium
The Fly
Eledon Pharmaceuticals initiated with a Buy at Craig-Hallum
4M ago
ELDN
Premium
Company Announcements
Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart
4M ago
ELDN
Premium
Ratings
Eledon Pharmaceuticals: Promising Advances in Organ Transplant Rejection Prevention with Tegoprubart
4M ago
ELDN
Premium
Ratings
Eledon Pharmaceuticals’ Tegoprubart: Promising Clinical Potential in Kidney Transplantation and Strategic Targeting Advantages
4M ago
ELDN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
